Sage Journals: Discover world-class research

Open access

Research article

First published 2016-11

Prevalence,Costs and Consequences of “Manovra AIFA” for ICS-LABA Treatment in Patients with Asthma or COPD: A Real-Practice Analysis

Alessandra Bettiol, Jenny Bolcato, Roberta Pirolo [...]

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Free access

Other

First published 2009-04

Clinical and pharmacoeconomic profile of COPD patients with FEV1 50—60% predicted: pilot study on the impact of the extended indication of ICS/LABA

Roberto Walter Dal Negro, Luca Bonadiman, Claudio Turati [...]

Therapeutic Advances in Respiratory Disease

Free access

Research article

First published 2011-4

The impact of LABA+ICS fixed combinations on morbidity and economic burden of COPD in Italy: a six-year observational study

Roberto Dal Negro, Luca Bonadiman, Silvia Tognella [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2020

LABA/LAMA fixed-dose combinations versus LAMA monotherapy in the prevention of COPD exacerbations: a systematic review and meta-analysis

Ching-Yi Chen, Wang-Chun Chen, Chi-Hsien Huang [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2022

Quantitative analysis of efficacy and safety of LABA/LAMA fixed-dose combinations in the treatment of stable COPD

Yiwen Gong, Yinghua Lv, Hongxia Liu [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2020

Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials

Sanjay Sethi, James F. Donohue, Gary T. Ferguson [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2009

Management of Asthma with ICS and LABAs: Different treatment strategies

M Van Den Berge, NHT Ten Hacken, HAM Kerstjens [...]

Clinical Medicine Insights: Therapeutics

Open access

Research article

First published 2024

Comparative effectiveness and safety of escalating to triple therapy versus switching to dual bronchodilators after discontinuing LABA/ICS in patients with COPD: a retrospective cohort study

Li-Wei Wu, Tzu-Chieh Lin, Tzu-Han Lin [...]

Therapeutic Advances in Respiratory Disease

Free access

Research article

First published 2013-12

The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects

Gregory J. Feldman, Anton Edin

Therapeutic Advances in Respiratory Disease

Retricted access

Research article

First published 2006-06

Long-acting Inhaled β 2 Agonists (LABAs) in Children and the New "Black Box" Warning

H. William Kelly

Pediatric Allergy,Immunology,and Pulmonology

Search results